Indonesia · Delayed Price · Currency is IDR IDX:MEDC Statistics
Total Valuation
IDX:MEDC has a market cap or net worth of IDR 35.36 trillion. The enterprise value is 93.09 trillion.
| Market Cap | 35.36T |
| Enterprise Value | 93.09T |
Important Dates
The next estimated earnings date is Tuesday, December 22, 2026.
| Earnings Date | Dec 22, 2026 |
| Ex-Dividend Date | Jun 15, 2026 |
Share Statistics
IDX:MEDC has 24.73 billion shares outstanding. The number of shares has decreased by -1.12% in one year.
| Current Share Class | 24.73B |
| Shares Outstanding | 24.73B |
| Shares Change (YoY) | -1.12% |
| Shares Change (QoQ) | +0.06% |
| Owned by Insiders (%) | 0.82% |
| Owned by Institutions (%) | 4.10% |
| Float | 6.19B |
Valuation Ratios
The trailing PE ratio is 5.72 and the forward PE ratio is 4.16.
| PE Ratio | 5.72 |
| Forward PE | 4.16 |
| PS Ratio | 0.76 |
| PB Ratio | 0.78 |
| P/TBV Ratio | 0.91 |
| P/FCF Ratio | 3.59 |
| P/OCF Ratio | 1.85 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 3.22, with an EV/FCF ratio of 9.46.
| EV / Earnings | 15.06 |
| EV / Sales | 2.00 |
| EV / EBITDA | 3.22 |
| EV / EBIT | 5.18 |
| EV / FCF | 9.46 |
Financial Position
The company has a current ratio of 1.69, with a Debt / Equity ratio of 1.72.
| Current Ratio | 1.69 |
| Quick Ratio | 1.48 |
| Debt / Equity | 1.72 |
| Debt / EBITDA | 3.12 |
| Debt / FCF | 7.90 |
| Interest Coverage | 2.43 |
Financial Efficiency
Return on equity (ROE) is 15.09% and return on invested capital (ROIC) is 7.37%.
| Return on Equity (ROE) | 15.09% |
| Return on Assets (ROA) | 5.70% |
| Return on Invested Capital (ROIC) | 7.37% |
| Return on Capital Employed (ROCE) | 10.27% |
| Weighted Average Cost of Capital (WACC) | 4.04% |
| Revenue Per Employee | 13.70B |
| Profits Per Employee | 1.82B |
| Employee Count | 3,402 |
| Asset Turnover | 0.30 |
| Inventory Turnover | 6.37 |
Taxes
In the past 12 months, IDX:MEDC has paid 5.85 trillion in taxes.
| Income Tax | 5.85T |
| Effective Tax Rate | 47.27% |
Stock Price Statistics
The stock price has decreased by -9.49% in the last 52 weeks. The beta is 0.02, so IDX:MEDC's price volatility has been lower than the market average.
| Beta (5Y) | 0.02 |
| 52-Week Price Change | -9.49% |
| 50-Day Moving Average | 1,421.30 |
| 200-Day Moving Average | 1,451.90 |
| Relative Strength Index (RSI) | 48.02 |
| Average Volume (20 Days) | 52,646,005 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, IDX:MEDC had revenue of IDR 46.62 trillion and earned 6.18 trillion in profits. Earnings per share was 250.45.
| Revenue | 46.62T |
| Gross Profit | 29.33T |
| Operating Income | 13.96T |
| Pretax Income | 12.37T |
| Net Income | 6.18T |
| EBITDA | 23.04T |
| EBIT | 13.96T |
| Earnings Per Share (EPS) | 250.45 |
Balance Sheet
The company has 23.73 trillion in cash and 77.69 trillion in debt, with a net cash position of -53,960.14 billion or -2,182.24 per share.
| Cash & Cash Equivalents | 23.73T |
| Total Debt | 77.69T |
| Net Cash | -53,960.14B |
| Net Cash Per Share | -2,182.24 |
| Equity (Book Value) | 45.24T |
| Book Value Per Share | 1,676.84 |
| Working Capital | 17.74T |
Cash Flow
In the last 12 months, operating cash flow was 19.14 trillion and capital expenditures -9,298.03 billion, giving a free cash flow of 9.84 trillion.
| Operating Cash Flow | 19.14T |
| Capital Expenditures | -9,298.03B |
| Depreciation & Amortization | 9.08T |
| Net Borrowing | 12.47T |
| Free Cash Flow | 9.84T |
| FCF Per Share | 397.84 |
Margins
Gross margin is 62.92%, with operating and profit margins of 29.95% and 13.26%.
| Gross Margin | 62.92% |
| Operating Margin | 29.95% |
| Pretax Margin | 26.54% |
| Profit Margin | 13.26% |
| EBITDA Margin | 49.42% |
| EBIT Margin | 29.95% |
| FCF Margin | 21.10% |
Dividends & Yields
This stock pays an annual dividend of 64.50, which amounts to a dividend yield of 4.51%.
| Dividend Per Share | 64.50 |
| Dividend Yield | 4.51% |
| Dividend Growth (YoY) | 48.95% |
| Years of Dividend Growth | 4 |
| Payout Ratio | 23.19% |
| FCF Payout Ratio | 15.26% |
| Buyback Yield | 1.12% |
| Shareholder Yield | 5.63% |
| Earnings Yield | 17.48% |
| FCF Yield | 27.82% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for IDX:MEDC is 2,115.77, which is 47.96% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 2,115.77 |
| Price Target Difference | 47.96% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 13 |
| Revenue Growth Forecast (3Y) | 5.09% |
| EPS Growth Forecast (3Y) | 71.58% |
Stock Splits
The last stock split was on September 11, 2017. It was a forward split with a ratio of 4.
| Last Split Date | Sep 11, 2017 |
| Split Type | Forward |
| Split Ratio | 4 |
Scores
IDX:MEDC has an Altman Z-Score of 1.17 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.17 |
| Piotroski F-Score | 7 |